Granisetron Base
Granisetron is an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-HT3 receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Product Name
CAS Number
109889-09-0
Therapeutic Class
Serotonin (5-HT3) receptor antagonist, Antiemetic
Dosage Form
Transdermal Patch, Extended-Release Injection for Subcutaneous use
Availability
Commercial
Regulatory Status
USDMF
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
